共有 50 笔近期内部人交易记录记录，涉及 ESSA Pharma Inc. (EPIX), 包括 18 笔买入 和 31 笔卖出. 内部人买入总额为 $11.57M 内部人卖出总额为 $10.93M.
近期活跃的重要内部人包括 Biotech Growth N V, Virsik Peter, Glickman Richard M. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — EPIX
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2024-11-01 |
Biotech Growth N V |
10 Percent Owner |
知情卖出 |
1,879,583 |
$1.51 |
$2.84M |
- |
| 2024-09-09 |
Virsik Peter |
Chief Operating Officer |
知情卖出 |
694 |
$6.00 |
$4.16K |
8,470 |
| 2024-09-03 |
Virsik Peter |
Chief Operating Officer |
知情卖出 |
2,082 |
$6.03 |
$12.55K |
9,164 |
| 2024-05-06 |
Virsik Peter |
Chief Operating Officer |
知情卖出 |
694 |
$6.95 |
$4.82K |
11,246 |
| 2024-04-24 |
Glickman Richard M |
Director |
期权行权（卖出） |
3,750 |
$4.90 |
$18.38K |
- |
| 2024-04-05 |
Virsik Peter |
Chief Operating Officer |
知情卖出 |
694 |
$7.94 |
$5.51K |
11,940 |
| 2024-03-25 |
Zweifach Sanford S |
Director |
限制性股票授予 (RSU) |
50,000 |
$9.04 |
$452K |
50,000 |
| 2024-03-25 |
Berger Franklin M |
Director |
限制性股票授予 (RSU) |
50,000 |
$9.04 |
$452K |
50,000 |
| 2024-03-25 |
Glickman Richard M |
Director |
限制性股票授予 (RSU) |
70,000 |
$9.04 |
$632.8K |
70,000 |
| 2024-03-25 |
Parkinson David Ross |
Chief Executive Officer |
限制性股票授予 (RSU) |
350,000 |
$9.04 |
$3.16M |
350,000 |
| 2024-03-25 |
Martin John Alexander |
Director |
限制性股票授予 (RSU) |
50,000 |
$9.04 |
$452K |
50,000 |
| 2024-03-25 |
Requadt Scott |
Director |
限制性股票授予 (RSU) |
50,000 |
$9.04 |
$452K |
50,000 |
| 2024-03-25 |
Virsik Peter |
Chief Operating Officer |
限制性股票授予 (RSU) |
110,000 |
$9.04 |
$994.4K |
110,000 |
| 2024-03-25 |
Thorell Marella |
Director |
限制性股票授予 (RSU) |
50,000 |
$9.04 |
$452K |
50,000 |
| 2024-03-25 |
Sollis Gary |
Director |
限制性股票授予 (RSU) |
50,000 |
$9.04 |
$452K |
50,000 |
| 2024-03-25 |
Wood David S. |
Chief Financial Officer |
限制性股票授予 (RSU) |
110,000 |
$9.04 |
$994.4K |
110,000 |
| 2024-03-25 |
Cesano Alessandra |
Chief Medical Officer |
限制性股票授予 (RSU) |
200,000 |
$9.04 |
$1.81M |
200,000 |
| 2024-03-25 |
Merendino Lauren |
Director |
限制性股票授予 (RSU) |
25,000 |
$9.04 |
$226K |
25,000 |
| 2024-03-25 |
Kantoff Philip W. |
Director |
限制性股票授予 (RSU) |
50,000 |
$9.04 |
$452K |
50,000 |
| 2024-03-05 |
Virsik Peter |
Chief Operating Officer |
知情卖出 |
694 |
$8.98 |
$6.23K |
12,634 |
| 2024-02-06 |
Virsik Peter |
Chief Operating Officer |
知情卖出 |
72,782 |
$10.29 |
$748.93K |
13,328 |
| 2024-02-05 |
Virsik Peter |
Chief Operating Officer |
知情卖出 |
500 |
$10.04 |
$5.02K |
13,328 |
| 2024-01-16 |
Virsik Peter |
Chief Operating Officer |
知情卖出 |
1,718 |
$10.01 |
$17.2K |
14,022 |
| 2024-01-05 |
Virsik Peter |
Chief Operating Officer |
知情卖出 |
699 |
$6.11 |
$4.27K |
14,022 |
| 2023-12-14 |
Parkinson David Ross |
Chief Executive Officer |
知情买入 |
9,223 |
$2.30 |
$21.21K |
65,675 |
| 2023-11-21 |
Berger Franklin M |
Director |
知情买入 |
23,259 |
$5.73 |
$133.27K |
784,404 |
| 2023-11-07 |
Parkinson David Ross |
Chief Executive Officer |
处置 |
171,470 |
$3.23 |
$553.85K |
- |
| 2023-11-07 |
Virsik Peter |
Chief Operating Officer |
处置 |
970,000 |
$3.23 |
$3.13M |
- |
| 2023-11-07 |
Wood David S. |
Chief Financial Officer |
处置 |
330,000 |
$3.23 |
$1.07M |
- |
| 2023-11-07 |
Cesano Alessandra |
Chief Medical Officer |
处置 |
400,000 |
$3.23 |
$1.29M |
- |
| 2023-11-06 |
Requadt Scott |
Director |
其他（卖出） |
12,500 |
- |
- |
30,002 |
| 2023-11-04 |
Berger Franklin M |
Director |
处置 |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-04 |
Glickman Richard M |
Director |
处置 |
30,000 |
$3.23 |
$96.9K |
- |
| 2023-11-04 |
Clarus Lifesciences Iii, L.p. |
10 Percent Owner |
未知 |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-04 |
Requadt Scott |
Director |
处置 |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-04 |
Brettman Ari David |
Director |
处置 |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-04 |
Thorell Marella |
Director |
处置 |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-04 |
Sollis Gary |
Director |
处置 |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-04 |
Zweifach Sanford S |
Director |
处置 |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-04 |
Martin John Alexander |
Director |
处置 |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-03 |
Berger Franklin M |
Director |
知情买入 |
16,471 |
$5.99 |
$98.66K |
760,875 |
| 2023-11-02 |
Berger Franklin M |
Director |
知情买入 |
60,000 |
$5.35 |
$321K |
744,404 |
| 2023-10-30 |
Requadt Scott |
Director |
其他（卖出） |
17,502 |
- |
- |
42,502 |
| 2023-10-24 |
Wood David S. |
Chief Financial Officer |
限制性股票授予 (RSU) |
3,750 |
$3.91 |
$14.66K |
3,750 |
| 2023-06-06 |
Merendino Lauren |
Director |
处置 |
50,000 |
$3.05 |
$152.5K |
- |
| 2023-03-08 |
Berger Franklin M |
Director |
处置 |
5,000 |
$3.81 |
$19.05K |
- |
| 2023-03-08 |
Glickman Richard M |
Director |
处置 |
10,000 |
$3.81 |
$38.1K |
- |
| 2023-03-08 |
Parkinson David Ross |
Chief Executive Officer |
处置 |
45,000 |
$3.81 |
$171.45K |
- |
| 2023-03-08 |
Requadt Scott |
Director |
处置 |
5,000 |
$3.81 |
$19.05K |
- |
| 2023-03-08 |
Virsik Peter |
Chief Operating Officer |
处置 |
40,000 |
$3.81 |
$152.4K |
- |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
